CPRIT funding fuels AI-powered cancer discovery at UT San Antonio

November 18, 2026

Stanford-trained structural biologist launches research program at UT San Antonio focused on the intersection of artificial intelligence, membrane proteins and colorectal cancer. The University of Texas at San Antonio (UT San Antonio) is expanding its cancer research enterprise through the recruitment of K. Ian White, PhD, a Stanford-trained structural biologist whose research brings together structural […]

Image of cancer detection



UT San Antonio researcher awarded grant to continue exploring dentin regeneration pathways

November 12, 2026

Researchers at The University of Texas at San Antonio Health Science Center are investigating how the body forms dentin, the hard tissue beneath tooth enamel, and how understanding this natural process could one day help regenerate dental tissue and repair damaged teeth. Shuo Chen, MD, PhD, professor of developmental dentistry at the UT San Antonio […]


UT San Antonio researchers discuss AI’s promise, challenges at brain health conferences

November 11, 2026

  Artificial intelligence (AI) is opening new possibilities for biomedical research, particularly in the field of brain health. AI shows promise for expanding what’s possible, from analyzing brain scans to expanding participation in studies of cognitive decline. At the same time, ensuring these technologies produce accurate, reliable results across populations remains a challenge. Presentations by […]


UT San Antonio hosts international brain health conferences advancing research into dementia, stroke

November 11, 2026

  Researchers from around the world gathered in downtown San Antonio Oct. 5-10 for two international brain health conferences hosted by The University of Texas at San Antonio (UT San Antonio). The conferences focused on the biological processes underlying Alzheimer’s disease and related dementias and stroke and strengthened collaborations that could help translate scientific discoveries […]


Decades in the making, MCAM enters initial human testing

November 10, 2026

After several years of development, a promising drug designed to prevent relapse to opioid use and opioid overdose is taking a critical step by entering human testing. In October, scientists at The University of Texas at San Antonio Health Science Center launched the first-in-human clinical trial of methocinnamox, or MCAM, a novel long-acting opioid receptor […]